Publication
Tamoxifeno e Espessamento Endometrial Assintomático
| dc.contributor.author | Amaral, N | |
| dc.contributor.author | Robalo, R | |
| dc.contributor.author | Fatela, A | |
| dc.date.accessioned | 2013-06-26T14:49:15Z | |
| dc.date.available | 2013-06-26T14:49:15Z | |
| dc.date.issued | 2008 | |
| dc.description.abstract | Tamoxifen is a first-line agent for adjuvant treatment of estrogen-receptor positive breast cancer, and is used to reduce the risk of this condition in high-risk individuals. Retrospective studies established an association between tamoxifen use, endometrial thickness and endometrial cancer. There have been many attempts to identify an effective screening program for tamoxifen-related endometrial cancer, which have led to the use of transvaginal ultrasound and invasive procedures. The use of a 5mm endometrial cut-off in vaginal ultrasound is known to raise the number of endometrial biopsies with no gain in early cancer diagnosis. A review of the scientific literature was performed in order to establish the best available evidence for endometrial evaluation of asymptomatic breast cancer patients on tamoxifen. | por |
| dc.identifier.citation | Acta Obstet Ginecol Port 2008;2(2):80-83 | por |
| dc.identifier.uri | http://hdl.handle.net/10400.17/1330 | |
| dc.language.iso | por | por |
| dc.peerreviewed | yes | por |
| dc.publisher | Sociedades Portuguesas de Obstetrícia e Ginecologia | por |
| dc.subject | Tamoxifeno | por |
| dc.subject | Estudos Retrospectivos | por |
| dc.subject | Diagnóstico | por |
| dc.title | Tamoxifeno e Espessamento Endometrial Assintomático | por |
| dc.title.alternative | Tamoxifen and Assymptomatic Endometrial Thickness | por |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 83 | por |
| oaire.citation.startPage | 80 | por |
| oaire.citation.title | Acta Obstétrica e Ginecológica Portuguesa | por |
| rcaap.rights | openAccess | por |
| rcaap.type | article | por |